Diagnostic Imaging Market to Register Growth with Rising R & D Investments


Overview:
However, the machines are quite costly, which can be a growth-deterring factor in developing regions. In several cases, unfavorable reimbursement policies are distracting patients from availing such services, which can be a hurdle for the market.

The global Diagnostic Imaging Market is witnessing increasing prospects that can guide the market towards a CAGR 6.2% and it would happen during the forecast period of 2018 to 2023, as per the latest published report by Market Research Future (MRFR). This report charts the course of the diagnostic imaging market and reveals possibilities in terms of factors and demography. Rising number of geriatric population, increasing registration of chronic disease patients, better technological inclusion, and others are expected to impact the market in the coming years. Governments are also ensuring a steady influx of investments that can trigger growth in research scopes that can impact better innovations.
Competitive Analysis:
Many of the key players in the global diagnostic imaging market are launching their own strategic schemes to make sure that they do not lag behind in the market. This includes primarily areas like mergers and acquisitions with special focus on product launches and innovations. These companies are Carestream Health, Esoate SpA, Hitachi Medical Systems, Koninklijke Philips N.V., CANON MEDICAL SYSTEMS CORPORATION, Toshiba Medical Systems Corporation, GE Healthcare, Siemens Healthcare Private Limited, FUJIFILM Holdings Corporation, Hologic Inc., and Shimadzu Corporation.
Segmentation:
·         The global diagnostic imaging market, as it has been discussed in the MRFR report, includes product type, application, and end-user to ensure that the players get a proper scope to get themselves armed with the latest market dynamics and insights.
·         By product type, the market for diagnostic imaging can be studied by having it segmented into ultrasound imaging systems, x-ray equipment, computed tomography (CT) scanners, magnetic resonance imaging (MRI), nuclear imaging systems, and other products.
·         By application, the market for diagnostic imaging has been segmented into oncology, gynecology, cardiology, orthopedics, neurology, gastroenterology, and other applications. The oncology segment is witnessing a surge in diagnostic cases as the rise in the early demand for cancer detection is impacting the medical strategies.
·         By the end-user, the report with a detailed understanding of the global diagnostic imaging market can be segmented into hospitals & clinics, research institutes, diagnostic centers, and others. The hospitals & clinics segment is set to grow more in the coming years as their space and investment capacity are better than the others, which can ensure higher cases of installation of such devices.
Regional Analysis:
The Americas has a well-established healthcare industry, which can boost the global practice of diagnostic imaging. This is primarily due to the high investment capacity, which is allowing easy inclusion of these technologies and expansion of the research & development sector. In addition, the regional awareness regarding the benefits of early diagnosis of these diseases can also trigger market growth. Increasing cases of chronic disorders and better reimbursement policies are set to redefine the regional market growth in the coming years. The number of patients seeking treatment for diabetes and cancer is quite high, which can ensure better growth. 
In Europe, the market is mostly doing well in countries like Germany, Russia, France, and the UK where the tailwinds are quite a few that can trigger market growth. These countries are known for their better industrial setup, improved research & development sector, and high spending capacity. In addition, early diagnostic procedures, led by reimbursement claims and growing awareness can also make sure that the market gets better growth opportunities.

Overview:
However, the machines are quite costly, which can be a growth-deterring factor in developing regions. In several cases, unfavorable reimbursement policies are distracting patients from availing such services, which can be a hurdle for the market.

The global Diagnostic Imaging Market is witnessing increasing prospects that can guide the market towards a CAGR 6.2% and it would happen during the forecast period of 2018 to 2023, as per the latest published report by Market Research Future (MRFR). This report charts the course of the diagnostic imaging market and reveals possibilities in terms of factors and demography. Rising number of geriatric population, increasing registration of chronic disease patients, better technological inclusion, and others are expected to impact the market in the coming years. Governments are also ensuring a steady influx of investments that can trigger growth in research scopes that can impact better innovations.
Competitive Analysis:
Many of the key players in the global diagnostic imaging market are launching their own strategic schemes to make sure that they do not lag behind in the market. This includes primarily areas like mergers and acquisitions with special focus on product launches and innovations. These companies are Carestream Health, Esoate SpA, Hitachi Medical Systems, Koninklijke Philips N.V., CANON MEDICAL SYSTEMS CORPORATION, Toshiba Medical Systems Corporation, GE Healthcare, Siemens Healthcare Private Limited, FUJIFILM Holdings Corporation, Hologic Inc., and Shimadzu Corporation.
Segmentation:
·         The global diagnostic imaging market, as it has been discussed in the MRFR report, includes product type, application, and end-user to ensure that the players get a proper scope to get themselves armed with the latest market dynamics and insights.
·         By product type, the market for diagnostic imaging can be studied by having it segmented into ultrasound imaging systems, x-ray equipment, computed tomography (CT) scanners, magnetic resonance imaging (MRI), nuclear imaging systems, and other products.
·         By application, the market for diagnostic imaging has been segmented into oncology, gynecology, cardiology, orthopedics, neurology, gastroenterology, and other applications. The oncology segment is witnessing a surge in diagnostic cases as the rise in the early demand for cancer detection is impacting the medical strategies.
·         By the end-user, the report with a detailed understanding of the global diagnostic imaging market can be segmented into hospitals & clinics, research institutes, diagnostic centers, and others. The hospitals & clinics segment is set to grow more in the coming years as their space and investment capacity are better than the others, which can ensure higher cases of installation of such devices.
Regional Analysis:
The Americas has a well-established healthcare industry, which can boost the global practice of diagnostic imaging. This is primarily due to the high investment capacity, which is allowing easy inclusion of these technologies and expansion of the research & development sector. In addition, the regional awareness regarding the benefits of early diagnosis of these diseases can also trigger market growth. Increasing cases of chronic disorders and better reimbursement policies are set to redefine the regional market growth in the coming years. The number of patients seeking treatment for diabetes and cancer is quite high, which can ensure better growth. 
In Europe, the market is mostly doing well in countries like Germany, Russia, France, and the UK where the tailwinds are quite a few that can trigger market growth. These countries are known for their better industrial setup, improved research & development sector, and high spending capacity. In addition, early diagnostic procedures, led by reimbursement claims and growing awareness can also make sure that the market gets better growth opportunities.


Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote...
Read more

Pancreatic Cancer Market: America to Command the Largest Share

Market Overview: Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global Pancreatic Cancer Market , as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period ( 2017-2023 ). The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging dem...
Read more

Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights: As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers. ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ...
Read more